Stavudine

Records for this ingredient, by country (identity only).

ATC J05AF04 · 6 markets · 26 records

Stavudine 6 markets · 26 records Forms
Filters
MarketGB 5CN 3HK 2

GB 5 records · 5 shown of 5 Source NHSBSA dm+d · Data as of 2026-10-19

CN 3 records · 2 shown of 2 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 15 mgcapsule欣复达司他夫定Manufacturer: 上海迪赛诺生物医药有限公司 also in GB
  • 20 mgcapsuleManufacturer: 上海迪赛诺生物医药有限公司 ×2 also in GB

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Stavudine 20mg capsules ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.